Filing Flows › Merck (MRK) › Free cash flow
Merck (MRK) free cash flow by quarter
Merck's free cash flow was $5.5B in Q3 2026 (third quarter 2026), +23% from Q2 2026. Over the last 7 quarters it ranged from $1.2B (Q1 2025) to $6.8B (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.5B | +23% | -19% |
| Q2 2026 | $4.5B | +53% | +77% |
| Q1 2026 | $2.9B | +60% | +150% |
| Q4 2025 | $1.8B | -73% | — |
| Q3 2025 | $6.8B | +170% | — |
| Q2 2025 | $2.5B | +116% | — |
| Q1 2025 | $1.2B | — | — |
Q3 2026 at a glance
Merck, Q3 2026: revenue $18.1B (+5% year over year), operating margin 30.7%, net earnings $5.1B, operating cash flow $6.6B. The chart follows the revenue to costs, profit and cash.
Questions
What is Merck's free cash flow?
Merck's free cash flow was $5.5B in Q3 2026 (third quarter 2026), +23% from Q2 2026.
How has Merck's free cash flow changed?
Over the last 7 quarters it ranged from $1.2B (Q1 2025) to $6.8B (Q3 2025).